Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:952-959
Published online before print September 29, 2008, doi: 10.1161/HYPERTENSIONAHA.108.111229
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
52/5/952    most recent
HYPERTENSIONAHA.108.111229v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jia, Z.
Right arrow Articles by Yang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jia, Z.
Right arrow Articles by Yang, T.
Related Collections
Right arrow Other hypertension
Right arrow Other Vascular biology

(Hypertension. 2008;52:952.)
© 2008 American Heart Association, Inc.


Original Articles

Microsomal Prostaglandin Synthase-1–Derived Prostaglandin E2 Protects Against Angiotensin II–Induced Hypertension via Inhibition of Oxidative Stress

Zhanjun Jia; Xiaohua Guo; Hui Zhang; Mong-Heng Wang; Zheng Dong; Tianxin Yang

From the Department of Internal Medicine (Z.J., X.G., H.Z., T.Y.), University of Utah and Veterans’ Affairs Medical Center, Salt Lake City; Departments of Physiology (M.-H.W.) and Cellular Biology and Anatomy (Z.D.), Medical College of Georgia, Augusta; and Medical Research Service (Z.D.), Veterans’ Affairs Medical Center, Augusta, Ga.

Correspondence to Tianxin Yang, University of Utah and VA Medical Center, 30 N 1900 E, Room 4R312, Salt Lake City, UT 84132. E-mail tianxin.yang{at}hsc.utah.edu

Prostaglandin (PG) E2 has an established role in the regulation of vascular tone and reactivity. The present study examined the role and mechanism of microsomal PG synthase-1 (mPGES-1) in vascular response to angiotensin II (Ang II) infusion. A 7-day Ang II infusion at 0.35 mg/kg per day via osmotic minipump had no obvious effect on mean arterial blood pressure in mPGES-1+/+ mice but induced a marked hypertensive response in mPGES-1–/– mice, associated with a parallel increase in urinary 8-isoprostane excretion and aortic NADPH oxidase activity and mRNA expression of p47phox, gp91phox, and Nox1. The hypertension in mPGES-1–/– mice was completely prevented by Tempol treatment and was fully restored on termination of the antioxidant. Apocynin induced a similar blood pressure–lowering effect as Tempol. The Ang II infusion induced mRNA expression of mPGES-1, as well as mPGES-2 and cytosolic PGE synthase in the aortas as assessed by real-time RT-PCR. Immunohistochemistry revealed remarkably enhanced immunoreactivity of mPGES-1 mostly in vascular smooth muscle cells. In cultured vascular smooth muscle cells, Ang II exerted a direct stimulatory effect on reactive oxygen species production, NADPH oxidase activity, and expression of p47phox, gp91phox, and Nox1 that were all inhibited by PGE2. The –/– mice also exhibited enhanced renal hemodynamic response to acute Ang II infusion at 150 nmol/kg per minute via a jugular vein over a period of 40 minutes. These results suggest that mPGES-1–derived PGE2 buffers Ang II–induced vasoconstriction via inhibition of NADPH oxidase–dependent reactive oxygen species production.


Key Words: mPGES-1 • angiotensin II • mean arterial pressure • oxidative stress • NADPH oxidase